{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:53:58Z","timestamp":1787313238512,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jtha.2025.01.008","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T12:14:47Z","timestamp":1738757687000},"page":"1522-1530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Andexanet-induced heparin resistance in cardiac surgery\u2014a rapid review of case reports and series"],"prefix":"10.1016","volume":"23","author":[{"given":"Yuko","family":"Mishima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shari C.","family":"Clifton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir L.","family":"Butt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kofi B.","family":"Vandyck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Boylan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5051-1365","authenticated-orcid":false,"given":"Kenichi A.","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.01.008_bib3","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMoa1814051","article-title":"Full study report of andexanet\u00a0alfa for bleeding associated with factor Xa inhibitors","volume":"380","author":"Connolly","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2025.01.008_bib4","article-title":"Successful nafamostat mesilate administration for andexanet\u00a0alfa-induced heparin resistance","volume":"15","author":"Kitaura","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jtha.2025.01.008_bib5","first-page":"454","article-title":"[Heparin resistance after administration of andexanet\u00a0alfa:report of a Case]","volume":"77","author":"Aratame","year":"2024","journal-title":"Kyobu Geka"},{"key":"10.1016\/j.jtha.2025.01.008_bib6","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1053\/j.jvca.2024.03.037","article-title":"Andexanet\u00a0alfa-induced heparin resistance: sustained anticoagulant inefficacy despite antithrombin therapy","volume":"38","author":"Nagashima","year":"2024","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jtha.2025.01.008_bib7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1213\/XAA.0000000000001115","article-title":"Andexanet\u00a0alfa use in patients requiring cardiopulmonary bypass: quo vadis?","volume":"13","author":"Levy","year":"2019","journal-title":"A\u00a0A Pract"},{"key":"10.1016\/j.jtha.2025.01.008_bib11","author":"Stevens"},{"key":"10.1016\/j.jtha.2025.01.008_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jclinepi.2020.10.007","article-title":"Cochrane rapid reviews methods group offers evidence-informed guidance to conduct rapid reviews","volume":"130","author":"Garritty","year":"2021","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jtha.2025.01.008_bib13","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jclinepi.2021.03.001","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"134","author":"Page","year":"2021","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jtha.2025.01.008_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1207\/S15328031US0203_03","article-title":"Interrater agreement measures: comments on kappan, Cohen\u2019s kappa, Scott\u2019s \u03c0, and Aickin\u2019s \u03b1","volume":"2","author":"Hsu","year":"2003","journal-title":"Understand Stat"},{"key":"10.1016\/j.jtha.2025.01.008_bib15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","article-title":"Methodological quality and synthesis of case series and case reports","volume":"23","author":"Murad","year":"2018","journal-title":"BMJ Evid Based Med"},{"key":"10.1016\/j.jtha.2025.01.008_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.jtha.2025.01.008_bib17","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1213\/ANE.0000000000003981","article-title":"Anticoagulation management and heparin resistance during cardiopulmonary bypass: a survey of Society of Cardiovascular Anesthesiologists Members","volume":"129","author":"Sniecinski","year":"2019","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jtha.2025.01.008_bib18","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jtha.2024.01.001","article-title":"Finding a common definition of heparin resistance in adult cardiac surgery: communication from the ISTH SSC subcommittee on perioperative and critical care thrombosis and hemostasis","volume":"22","author":"Levy","year":"2024","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.008_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/ejcts\/ezad100","article-title":"Andexanet\u00a0alfa in acute aortic syndrome: first UK experience","volume":"63","author":"Al-Attar","year":"2023","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtha.2025.01.008_bib20","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1053\/j.jvca.2020.10.042","article-title":"Successful antithrombin administration in andexanet\u00a0alfa-associated heparin resistance","volume":"35","author":"Apostel","year":"2021","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jtha.2025.01.008_bib21","article-title":"Heparin insensitivity and thrombotic risk associated with sequential uses of prothrombin complex concentrate and andexanet\u00a0alfa for apixaban reversal during acute type A aortic dissection repair: a case report","volume":"16","author":"Brenner","year":"2022","journal-title":"A\u00a0A Pract"},{"key":"10.1016\/j.jtha.2025.01.008_bib22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1213\/XAA.0000000000001052","article-title":"Andexanet\u00a0alfa for urgent reversal of apixaban before aortic surgery requiring cardiopulmonary bypass: a case report","volume":"13","author":"Flaherty","year":"2019","journal-title":"A\u00a0A Pract"},{"key":"10.1016\/j.jtha.2025.01.008_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40981-023-00619-7","article-title":"Successful use of an antithrombin for heparin resistance with andexanet\u00a0alfa","volume":"9","author":"Honda","year":"2023","journal-title":"JA Clin Rep"},{"key":"10.1016\/j.jtha.2025.01.008_bib24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4326\/jjcvs.53.127","article-title":"A\u00a0case of acute aortic dissection treated with nafamostat for heparin resistance caused by a DOAC reversal agent","volume":"53","author":"Morimoto","year":"2024","journal-title":"J\u00a0Jpn Soc Cardiovasc Surg"},{"key":"10.1016\/j.jtha.2025.01.008_bib25","first-page":"98","article-title":"Acute aortic dissection resulting in marked heparin resistance after preoperative administration of andexanet\u00a0alfa: a case report","volume":"73","author":"Morishige","year":"2024","journal-title":"Masui"},{"key":"10.1016\/j.jtha.2025.01.008_bib26","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1053\/j.jvca.2023.12.001","article-title":"Cardiopulmonary bypass circuit obstruction and urgent replacement after the administration of andexanet\u00a0alfa","volume":"38","author":"Nozumi","year":"2024","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jtha.2025.01.008_bib27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40981-024-00690-8","article-title":"Andexanet\u00a0alpha-induced heparin resistance treated by nafamostat mesylate in a patient undergoing total aortic arch repair for Stanford type A acute aortic dissection: a case report","volume":"10","author":"Suzuki","year":"2024","journal-title":"JA Clin Rep"},{"key":"10.1016\/j.jtha.2025.01.008_bib28","article-title":"A\u00a0case of andexanet\u00a0alfa induced heparin resistance in emergent aortic surgery: successful anticoagulation management using antithrombin administration","volume":"15","author":"Takagi","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jtha.2025.01.008_bib29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.5551\/jat.64223","article-title":"Andexanet\u00a0alfa for the reversal of factor Xa inhibitor activity: prespecified subgroup analysis of the ANNEXA-4 Study in Japan","volume":"31","author":"Toyoda","year":"2024","journal-title":"J\u00a0Atheroscler Thromb"},{"key":"10.1016\/j.jtha.2025.01.008_bib30","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.bja.2024.02.027","article-title":"Antithrombin supplementation attenuates heparin resistance in plasma spiked with Gla-domainless factor Xa S195A in\u00a0vitro","volume":"132","author":"Mishima","year":"2024","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jtha.2025.01.008_bib31","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/jth.15697","article-title":"Regulation of coagulation by tissue factor pathway inhibitor: Implications for hemophilia therapy","volume":"20","author":"Mast","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.008_bib32","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1182\/blood-2014-10-604587","article-title":"Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor","volume":"125","author":"Puy","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.01.008_bib33","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.athoracsur.2021.03.033","article-title":"STS\/SCA\/AmSECT\/SABM update to the clinical practice guidelines on patient blood management","volume":"112","author":"Tibi","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtha.2025.01.008_bib34","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00000542-200205000-00011","article-title":"Recombinant human transgenic antithrombin in cardiac surgery: a dose-finding study","volume":"96","author":"Levy","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jtha.2025.01.008_bib35","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/j.athoracsur.2008.02.037","article-title":"Treating heparin resistance with antithrombin or fresh frozen plasma","volume":"85","author":"Spiess","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtha.2025.01.008_bib36","doi-asserted-by":"crossref","first-page":"571","DOI":"10.5301\/IJAO.2011.8535","article-title":"Nafamostat mesilate as an anticoagulant during continuous veno-venous hemodialysis: a three-year retrospective cohort study","volume":"34","author":"Maruyama","year":"2011","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.jtha.2025.01.008_bib37","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.athoracsur.2016.01.044","article-title":"Anticoagulation during extracorporeal membrane oxygenation; nafamostat mesilate versus heparin","volume":"102","author":"Lim","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtha.2025.01.008_bib38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1527-3466.1995.tb00213.x","article-title":"Nafamostat mesilate","volume":"13","author":"Okajima","year":"1995","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1016\/j.jtha.2025.01.008_bib39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/j.jvca.2011.09.002","article-title":"Nafamostat mesilate, as a treatment for heparin resistance, is not associated with perioperative ischemic stroke in patients undergoing cardiac surgery with cardiopulmonary bypass","volume":"26","author":"Kikura","year":"2012","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jtha.2025.01.008_bib40","first-page":"II410","article-title":"Aprotinin and heparin monitoring during cardiopulmonary bypass","volume":"86","author":"Hunt","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2025.01.008_bib41","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1067\/mtc.2002.119060","article-title":"Antithrombin III concentrate to treat heparin resistance in patients undergoing cardiac surgery","volume":"123","author":"Lemmer","year":"2002","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtha.2025.01.008_bib42","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1053\/jcan.2003.42","article-title":"Management of heparin resistance during cardiopulmonary bypass: the effect of five different anticoagulation strategies on hemostatic activation","volume":"17","author":"Koster","year":"2003","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jtha.2025.01.008_bib43","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1053\/j.jvca.2020.08.017","article-title":"Intraoperative off-label reversal of apixaban by andexanet\u00a0alfa while on VA-ECMO immediately after emergent surgery for acute type A aortic dissection","volume":"35","author":"Kainz","year":"2021","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jtha.2025.01.008_bib44","article-title":"The double edged sword: andexanet\u00a0alpha administration in aortic dissection leading to intracardiac thrombosis","author":"Brush","year":"2024","journal-title":"Anesthesiology Annual Meeting, Philadelphia, PA"},{"key":"10.1016\/j.jtha.2025.01.008_bib45","article-title":"Andexanet\u00a0alfa for edoxaban reversal and associated thromboelastography changes in surgical pulmonary embolectomy","volume":"16","author":"Fukuda","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.jtha.2025.01.008_bib46","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nm.3102","article-title":"A\u00a0specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa","volume":"19","author":"Lu","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.jtha.2025.01.008_bib47","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jclinepi.2013.08.003","article-title":"The CARE guidelines: consensus-based clinical case report guideline development","volume":"67","author":"Gagnier","year":"2014","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jtha.2025.01.008_bib48","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A\u00a0method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625000509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625000509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:37:22Z","timestamp":1777639042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625000509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1538783625000509"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.01.008","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Andexanet-induced heparin resistance in cardiac surgery\u2014a rapid review of case reports and series","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}